LOSS OF HETEROZYGOSITY OF TUMOR-SUPPRESSOR GENES IN TESTIS CANCER

被引:0
|
作者
PENG, HQ
BAILEY, D
BRONSON, D
GOSS, PE
HOGG, D
机构
[1] TORONTO HOSP, DIV ONCOL RES, TORONTO, ON M5G 2C4, CANADA
[2] TORONTO HOSP, DEPT PATHOL, TORONTO, ON M5G 2C4, CANADA
[3] UNIV MINNESOTA, SCH MED, DEPT UROL, MINNEAPOLIS, MN 55455 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Little is known of the molecular changes that occur in germ cell tumors (GCT) of the testis. We studied three GCT cell lines and 44 tumors for loss of heterozygosity (LOH) of the tumor suppressor genes APC, MCC, DCC, RE, TP53, and WT-1. We observed that LOH occurred in 55% (21 of 38) of informative cases at DCC, in 28% (10 of 36) of informative cases at APC,in 23% (6 of 26) at MCC, in 30% (13 of 43) at RB, and in 27% (6 of 22) at WT-1. The LOH level in these tumors using anonymous primers mapping to the short and long arms of chromosome 19, which is cytogenetically normal in GCT, revealed LOH of 11 and 5%, respectively. We also observed a LOH of 22% in the TP53 gene, despite the fact that mutations in TP53 do not occur in testis cancer. Since a high frequency of LOH at DCC (18q21.3) occurs equally at all histological subsets in GCT, we conclude that the loss of the function of this gene is an early event in testicular GCTs. However, the observed LOH levels at APC/MCC (5q21), RE (13q14), and WT-1 (11p13) could represent a functional loss of the corresponding tumor suppressor gene in some GCTs or reflect the loss of sequences in the same general chromosome region but involving a different tumor suppressor locus. Therefore, detailed mapping of these chromosomes is required to define the precise locations of maximal LOH in testis cancer.
引用
收藏
页码:2871 / 2875
页数:5
相关论文
共 50 条
  • [31] Loss of heterozygosity of selected tumor suppressor genes in parathyroid carcinoma DISCUSSION
    Clark, Orlo H.
    Yip, Linwah
    Singh, Bhuyanejh
    Politz, Doug
    Sosa, Julie Ann
    SURGERY, 2008, 144 (06) : 954 - 955
  • [32] Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence
    Thiagalingam, S
    Foy, RL
    Cheng, KH
    Lee, HJ
    Thiagalingam, A
    Ponte, JF
    CURRENT OPINION IN ONCOLOGY, 2002, 14 (01) : 65 - 72
  • [33] Loss of heterozygosity of major tumor suppressor genes in invasive ductal carcinomas
    Byun, Woo Seok
    Park, Chan Heun
    Cho, Seong Jin
    Ahn, Hye Gyung
    Nam, Eun Sook
    Cha, Hee Jung
    Kim, Kwan Suk
    JOURNAL OF BREAST CANCER, 2007, 10 (01) : 68 - 76
  • [34] THE USE OF ALLELE LOSS TO DEFINE NEW TUMOR-SUPPRESSOR GENES IN LYMPHOMA
    MORGAN, GJ
    RANDERSON, J
    QUIRKE, P
    LEWIS, F
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 104 - 104
  • [35] Somatic and Germinal Mutations of Tumor-Suppressor Genes in the Development of Cancer
    Sasaki, Masao S.
    Kato, Mitsuo
    Toguchida, Junya
    Yamaguchi, Toshikazu
    Ejima, Yosuke
    Ishizaki, Kanji
    Kaneko, Akihiro
    Tanooka, Hiroshi
    Journal of Radiation Research, 1991, 32 (Suppl_2) : 266 - 276
  • [36] TUMOR-SUPPRESSOR GENES AND RISK OF METASTASIS IN OVARIAN-CANCER
    LOWRY, WS
    ATKINSON, RJ
    BRITISH MEDICAL JOURNAL, 1993, 307 (6903): : 542 - 542
  • [37] TUMOR-SUPPRESSOR GENES - NEW PERSPECTIVES FOR INVESTIGATION IN HUMAN CANCER
    PAVAN, J
    GUALANDI, F
    RIMESSI, P
    CORALLINI, A
    BARBANTIBRODANO, G
    MEDICINA-BUENOS AIRES, 1994, 54 (02) : 163 - 168
  • [38] TUMOR-SUPPRESSOR GENES IN MOLECULAR MEDICINE
    HOPPESEYLER, F
    BUTZ, K
    CLINICAL INVESTIGATOR, 1994, 72 (08): : 619 - 630
  • [39] Reacativation of tumor-suppressor genes by demethylation in human gastric cancer
    Cheng, Yuen Yee
    Jin, Victor X.
    Chan, Michael W. Y.
    Leung, Wai Keung
    Sung, Joseph J. Y.
    Huang, Tim Hui-Ming
    Chan, Francis K. L.
    CANCER RESEARCH, 2006, 66 (08)
  • [40] ONCOGENES AND TUMOR-SUPPRESSOR GENES IN THE PATHOGENESIS OF LUNG-CANCER
    WIETHEGE, T
    VOSS, B
    MULLER, KM
    PATHOLOGE, 1994, 15 (06): : 321 - 330